Skip to main content
SpringerLink
Log in

Alpelisib

Colitis: 20 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sullivan KM, et al. Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration. JAMA Oncology 8: 1503-1505, No. 10, Oct 2022. Available from: URL: http://doi.org/10.1001/jamaoncol.2022.3249

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alpelisib. Reactions Weekly 1941, 27 (2023). https://doi.org/10.1007/s40278-023-32290-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-32290-7

Search

Navigation